Exelon (NASDAQ:EXC) Price Target Raised to $54.00

Exelon (NASDAQ:EXC) had its target price hoisted by Wells Fargo & Company from $49.00 to $54.00 in a research note issued to investors on Wednesday morning, The Fly reports. They currently have an overweight rating on the stock.

A number of other equities research analysts have also recently issued reports on the stock. Credit Suisse Group dropped their price target on shares of Exelon from $49.00 to $47.00 and set an outperform rating on the stock in a research note on Monday, March 1st. Bank of America raised shares of Exelon from a neutral rating to a buy rating in a research note on Wednesday, January 6th. Morgan Stanley dropped their price target on shares of Exelon from $56.00 to $55.00 and set an overweight rating on the stock in a research note on Thursday, February 25th. TheStreet cut shares of Exelon from a b rating to a c+ rating in a research note on Thursday, March 18th. Finally, Argus lifted their price target on shares of Exelon from $42.00 to $45.00 and gave the company a buy rating in a research note on Friday, December 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. Exelon presently has a consensus rating of Buy and an average price target of $45.18.

NASDAQ:EXC opened at $44.95 on Wednesday. The company has a debt-to-equity ratio of 1.02, a current ratio of 1.09 and a quick ratio of 0.94. The firm has a market cap of $43.91 billion, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 5.31 and a beta of 0.41. The company has a 50 day moving average price of $41.95 and a 200-day moving average price of $42.07. Exelon has a 1-year low of $33.97 and a 1-year high of $46.02.

Exelon (NASDAQ:EXC) last posted its earnings results on Tuesday, February 23rd. The company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.07. The firm had revenue of $8.12 billion during the quarter, compared to analyst estimates of $8.30 billion. Exelon had a net margin of 7.15% and a return on equity of 9.24%. During the same period in the previous year, the firm earned $0.83 EPS. On average, sell-side analysts anticipate that Exelon will post 3.1 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Monday, March 15th. Shareholders of record on Monday, March 8th were paid a dividend of $0.3825 per share. This represents a $1.53 annualized dividend and a yield of 3.40%. The ex-dividend date of this dividend was Friday, March 5th. This is a boost from Exelon’s previous quarterly dividend of $0.38. Exelon’s payout ratio is 47.52%.

In other news, CEO Carim V. Khouzami sold 12,239 shares of Exelon stock in a transaction on Thursday, March 18th. The stock was sold at an average price of $42.88, for a total transaction of $524,808.32. Following the transaction, the chief executive officer now owns 635 shares in the company, valued at approximately $27,228.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.34% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Cliftonlarsonallen Wealth Advisors LLC raised its holdings in shares of Exelon by 0.5% during the 4th quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 48,456 shares of the company’s stock worth $2,046,000 after acquiring an additional 256 shares during the period. Northwest Bancshares Inc. raised its holdings in shares of Exelon by 2.5% during the 4th quarter. Northwest Bancshares Inc. now owns 10,835 shares of the company’s stock worth $457,000 after acquiring an additional 268 shares during the period. GWM Advisors LLC raised its holdings in shares of Exelon by 3.3% during the 4th quarter. GWM Advisors LLC now owns 8,307 shares of the company’s stock worth $351,000 after acquiring an additional 269 shares during the period. Eudaimonia Partners LLC raised its holdings in shares of Exelon by 2.1% during the 3rd quarter. Eudaimonia Partners LLC now owns 13,961 shares of the company’s stock worth $499,000 after acquiring an additional 289 shares during the period. Finally, United Asset Strategies Inc. raised its holdings in shares of Exelon by 4.0% during the 4th quarter. United Asset Strategies Inc. now owns 7,988 shares of the company’s stock worth $337,000 after acquiring an additional 304 shares during the period. Institutional investors and hedge funds own 76.59% of the company’s stock.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.

Read More: Why is the ex-dividend date different from the record date?

The Fly

Analyst Recommendations for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.